GWO XI STEM CELL APPLIED TECHNOLOGY CO LTD
6704 | Gretai Securities MarketBusiness Summary
Gwo Xi Stem Cell Applied Technology Co Ltd is a Taiwan-based company mainly engaged in the development of stem cell drugs and technologies for the treatment of refractory diseases. The Company owns the Medical-Grade Cell Preparation Platform for the collection, isolation, culture, scaling up, packaging, testing, transportation, storage and treatment of human stem cells. The platform is modularized to create the stem cell activation technology Nigiro-Med, medical grade stem cell storage service and clinical cell preparation quality testing service. The Company operates through Stem Cell Freezing segment, Health Care Products and Maintenance Products segment, and Other segment.
Country of Incorporation
Taiwan
Incorporation Date
2004-03-26
Business Sector
Pharmaceuticals & Medical Research
Company Address
No.2, Shengyi 3rd Road
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
